Trademark Overview
On Tuesday, October 31, 2023, a trademark application was filed for CRISPR-X with the United States Patent and Trademark Office. The USPTO has given the CRISPR-X trademark a serial number of 98247548. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, August 8, 2024. This trademark is owned by CRISPR Therapeutics AG. The CRISPR-X trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, t...
